Nitric-Oxide-Releasing Dexamethasone Derivative NCX-1005 Improves Lung Function and Attenuates Inflammation in Experimental Lavage-Induced ARDS

Acute respiratory distress syndrome (ARDS) is a common complication of critical illness and remains a major source of morbidity and mortality in the intensive care unit (ICU). ARDS is characterised by diffuse lung inflammation, epithelial and endothelial deterioration, alveolar–capillary leak and oe...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Petra Kosutova, Maros Kolomaznik, Andrea Calkovska, Daniela Mokra, Pavol Mikolka
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2021-12-01
Edice:	Pharmaceutics
Témata:	NCX-1005 nitro-steroid nitric oxide donor dexamethasone ARDS animal model
On-line přístup:	https://www.mdpi.com/1999-4923/13/12/2092
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!